US Broker Ratings

Celcuity Inc. (CELC) Investor Outlook: Biotechnology Innovator with 75% Potential Upside

Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, has captured the attention of investors with its promising drug development pipeline and a striking potential upside of..

Growth Potential for Personalis, Inc. (PSNL): A Look at its 30% Revenue Surge

Personalis, Inc. (NASDAQ: PSNL), a prominent player in the Diagnostics & Research industry within the Healthcare sector, is drawing investor attention with its promising revenue growth..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: Exploring a 43% Upside Potential in Biotechnology

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company, is capturing the attention of investors with its promising outlook in the biotechnology sector. Headquartered in New..

Neuropace, Inc. (NPCE) Stock Analysis: A 45% Potential Upside Awaits Investors

Neuropace, Inc. (NASDAQ: NPCE) is drawing significant attention in the healthcare sector, specifically within the innovative realm of medical devices. Known for its pioneering RNS System,..

Tyra Biosciences (TYRA) Stock Analysis: A Biotech with 92% Upside Potential

Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology company, has captured investor attention with its promising pipeline and remarkable upside potential. With an impressive projected upside..

RxSight, Inc. (RXST) Stock Analysis: Exploring a 30% Potential Upside in the Healthcare Sector

RxSight, Inc. (NASDAQ: RXST) is a company that’s drawing attention within the medical devices industry, particularly for its innovative approach in enhancing vision post-cataract surgery. As..

Prothena Corporation plc (PRTA) Stock Analysis: 149% Potential Upside Ignites Investor Interest

Prothena Corporation plc (NASDAQ: PRTA), a prominent player in the biotechnology sector, is capturing investor attention with its promising pipeline of novel therapies aimed at treating..

Standard BioTools Inc. (LAB) Stock Report: Evaluating a Potential 93% Upside in the Medical Devices Sector

Standard BioTools Inc. (NASDAQ: LAB), a player in the healthcare sector specializing in medical devices, has captured investor interest with its significant potential upside of nearly..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating Challenges with a 7.75% Upside Potential

Community Health Systems, Inc. (NYSE: CYH), a prominent player in the healthcare sector, operates a network of general acute care hospitals throughout the United States. Headquartered..

Arvinas, Inc. (ARVN) Stock Analysis: Exploring a 67.87% Potential Upside for Investors

Arvinas, Inc. (NASDAQ: ARVN), a clinical-stage biotechnology company based in New Haven, Connecticut, is making waves in the healthcare sector with its innovative approach to protein..

Cel-Sci Corporation (CVM) Stock Analysis: Exploring a 676% Potential Upside in Biotech

Cel-Sci Corporation (NASDAQ: CVM) is a clinical-stage biotechnology firm that has captured the attention of investors with its promising pipeline and significant upside potential. Specializing in..

EyePoint, Inc. (EYPT) Stock Analysis: Unpacking a 218% Potential Upside in the Biotech Sector

EyePoint, Inc. (NASDAQ: EYPT) is a notable player in the biotechnology industry, focusing on innovative treatments for retinal diseases. With its proprietary Durasert E technology, EyePoint..

Eton Pharmaceuticals (ETON) Stock Analysis: Exploring an 18.56% Upside Potential

Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a burgeoning player in the healthcare sector with a focus on rare diseases, has been capturing the attention of investors. With..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring the 221% Potential Upside

Definitive Healthcare Corp. (DH) has been capturing investor interest with its healthcare commercial intelligence platform, a key player in the burgeoning health information services industry. Headquartered..

Septerna, Inc. (SEPN) Stock Analysis: Unveiling Growth Potential with a 13.84% Upside

Septerna, Inc. (NASDAQ: SEPN), a clinical-stage biotechnology company, is making significant waves in the healthcare sector with its innovative approach to treating complex diseases. With a..

AtaiBeckley Inc. (ATAI): Investor Outlook with a 33.53% Potential Upside Amid Clinical Innovations

AtaiBeckley Inc. (NASDAQ: ATAI), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to mental health treatments. Despite recent financial..

Amylyx Pharmaceuticals (AMLX) Stock Analysis: Strong Buy Ratings and Promising Drug Pipeline Signal Growth Potential

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has been garnering significant attention in the healthcare sector, particularly in the specialty and generic drug manufacturing industry. With its current..

Fortrea Holdings Inc. (FTRE): Investor Outlook Reveals Potential 16% Upside in Biotechnology Sector

In the dynamic world of biotechnology, Fortrea Holdings Inc. (NASDAQ: FTRE) stands out as a promising player. Despite facing some challenges, the company’s potential for growth..

KalVista Pharmaceuticals (KALV) Stock Report: The Flat Line in Biotech Valuation

KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a prominent player in the biotech sector, has captured investor attention with its recent transition from a public entity to a..

Butterfly Network, Inc. (BFLY) Stock Analysis: A High-Flying Medical Device Innovator with a 39.5% Revenue Growth

Butterfly Network, Inc. (NASDAQ: BFLY) is making waves in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $2.21 billion, the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds